Arcadia Biosciences Inc
F:17DN

Watchlist Manager
Arcadia Biosciences Inc Logo
Arcadia Biosciences Inc
F:17DN
Watchlist
Price: 0.2024 EUR -3.25% Market Closed
Market Cap: €124.7k

Wall St Price Targets

17DN Price Targets Summary
Arcadia Biosciences Inc

There are no price targets for 17DN.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Arcadia Biosciences Inc Competitors:
Price Targets
SAN
Banco Santander SA
3% Upside

Revenue
Forecast

-2% / Year
Past Growth
62% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss
-2% / Year
Past Growth
62% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Over the last 12 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 1 year is 62%.

Gross Profit
Forecast

-9% / Year
Past Growth
35% / Year
Estimated Growth
Estimates Accuracy
-29%
Average Miss
-9% / Year
Past Growth
35% / Year
Estimated Growth
Estimates Accuracy
-29%
Average Miss

Over the last 12 years, the compound annual growth rate for Gross Profit has been -9%. The projected CAGR for the next 1 year is 35%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 17DN's stock price target?
Not Available

17DN does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Arcadia Biosciences Inc?
Projected CAGR
62%

Over the last 12 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 1 year is 62%.

What is the Gross Profit forecast for Arcadia Biosciences Inc?
Projected CAGR
35%

Over the last 12 years, the compound annual growth rate for Gross Profit has been -9%. The projected CAGR for the next 1 year is 35%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett